SCHEMBL19494647

SCHEMBL19494647

CC1CN(SN(O)c2cc(C(N)=O)c(NC(=O)C3(O)CC3)s2)CC(C)O1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 2/20 0.41
▸ MAPK8 P45983 1/20 0.37
▸ MEN1 O00255 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CHEK1 O14757 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.31
▸ ATM Q13315 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ GFER P55789 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494611 0.83 CFTR (0.45) CFTRMEN1ALDH1A1KMT2AKDM4E
SCHEMBL16338203 0.75 CFTR (0.54) CFTRMAPK8MEN1ALDH1A1KMT2A
SCHEMBL19494440 0.72 MAPK1 (0.31) MAPK1GFER
SCHEMBL19494728 0.70 CFTR (0.50) CFTRMAPK8MEN1KMT2ACHEK1
SCHEMBL19494636 0.68 CFTR (0.43) CFTRMAPK8MEN1ALDH1A1KMT2A
SCHEMBL19494313 0.68 IKBKB (0.32) MEN1ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL19494401 0.68 CFTR (0.46) CFTRMEN1ALDH1A1KMT2AKDM4E
SCHEMBL16246534 0.67 CFTR (0.51) CFTRMEN1ALDH1A1KMT2AKDM4E
SCHEMBL16246527 0.66 CFTR (0.58) CFTRMEN1ALDH1A1KMT2ALMNA
SCHEMBL19494695 0.66 MAPK1 (0.41) CFTRMEN1ALDH1A1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback